RC | RC inc. s-IgE ≥ 4.00 SU/ml | Allergic RC | Allergic RC inc s-IgE ≥ 4.00 SU/ml | Non-allergic RC | |
---|---|---|---|---|---|
aOR (CI 95%) | aOR (CI 95%) | aOR (CI 95%) | aOR (CI 95%) | aOR (CI 95%) | |
Gender | 1.26 (0.78–2.04) | 1.30 (0.80–2.12) | 1.90 (1.06–3.41)* | 2.08 (1.14–3.81)* | 0.64 (0.31–1.32) |
FH | 2.01 (1.25–3.23)* | 2.01 (1.24–3.26)* | 2.25 (1.27–3.99)* | 2.32 (1.28–4.18)* | 1.45 (0.72–2.92) |
Early sensitization to inhalant allergens | 1.31 (0.78–2.20) | 1.65 (0.91–3.02) | NI | ||
Early sensitization to foods | 1.62 (0.99–2.67)* | 1.57 (0.86–2.87) | NI | ||
s-IgE ≥ 4.00 SU/ml to inhalant allergens | 2.03 (1.06–3.90)* | 2.92 (1.43–5.96)* | NI | ||
s-IgE ≥ 4.00 SU/ml to food allergens | 2.38 (1.15–4.93)* | 3.13 (1.41–6.95)* | NI | ||
FA | 3.49 (1.00–12.16) | 2.36 (0.62–8.92) | 3.89 (1.08–14.08)* | 2.08 (0.52–8.31) | NI |
AD | 2.44 (1.37–4.33)* | 2.11 (1.17–3.81)* | 3.24 (1.72–6.12)* | 2.68 (1.38–5.19)* | NI |
ETS | 0.42 (0.26–0.69)* | 0.42 (0.26–0.69)* | 0.47 (0.26–0.83)* | 0.48 (0.27–0.87)* | 0.43 (0.20–0.92)* |
Maternal tobacco smoking in pregnancy | NI | NI | NI | NI | 0.56 (0.21–1.46) |
Older siblings | 0.64 (0.40–1.03) | 0.66 (0.41–1.07) | 0.53 (0.30–0.94)* | 0.55 (0.31–1.00) |